Research Partners & Initiatives
The Lymphangiomatosis & Gorham’s Disease Alliance works closely with the Lymphatic Malformation Institute (LMI) to promote and fund research and is the sponsor of the International LGDA Registry for Lymphatic Malformations, which collects medical and demographic information about patients with lymphangiomatosis and Gorham’s disease, as well as other lymphatic malformations and osteolytic bone diseases.
The Lymphatic Malformation Institute(LMI) was established in December, 2010, and is focused, as a whole, on advancing the understanding of the lymphatic system and, specifically, advancing the understanding of the rare lymphatic malformations, lymphangiomatosis and Gorham’s disease.
The goal of the LMI is to find cures and treatments for these life-threatening disorders that have received very little attention from the scientific community in the past. The LMI seeks to fill this critical gap by identifying, organizing and funding research studies by medical and research professionals, and also working closely with other foundations, such as the LGDA, with similar objectives.
The LMI’s focused strategy includes the following initiatives:
- Identify, fund and systematically monitor research projects that further our understanding of lymphatic biology, especially as it relates to lymphangiomatosis and Gorham’s disease.
- Support development and sharing of laboratory tools and reagents critical to conducting research.
- Fund and monitor the progress of clinical trials, new treatments and medications that may help to treat the many complications that can arise from lymphatic malformations.
- Promote and support a culture of collaboration and communication between medical professionals, research professionals, patient support groups and patients themselves in which all are put in the best position for beneficial outcomes.
For more information about the LMI and its program, including funding opportunities and projects underway, visit their website.
The Lymphangiomatosis and Gorham’s Disease Alliance (LGDA) established the International LGDA Registry for Lymphatic Malformations (LGDA Registry) as an internet-based information database for researchers and clinicians, as well as an information network for individuals with lymphangiomatosis and Gorham’s disease and their families as a means to achieving its ultimate goal of developing cures for these diseases. The LGDA Registry is also open to individuals affected by a number of other lymphatic malformations and osteolytic bone diseases. The registry will collect and analyze information about patients with these conditions in order to expand the basic knowledge about these diseases and their impact on patients and families; assess gaps in service; promote access to care; develop best standards of practice for diagnosis and clinical management; and connect families to research opportunities. The LGDA Registry is a critical part of the LGDA’s efforts to raise awareness of these diseases; provide patients and their families with information and a strong support network; and improve the quality of care of individuals with lymphangiomatosis, Gorham’s disease, other lymphatic malformations, and osteolytic bone diseases.